Crowell, Valerie
Reyes, Adriana
Zhou, Summera Qiheng
Vassilaki, Maria
Gsteiger, Sandro
Gustavsson, Anders
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Article History
Received: 2 February 2023
Accepted: 2 August 2023
First Online: 14 August 2023
Declarations
:
: Research using the National Alzheimer’s Coordinating Center database was approved by the University of Washington Institutional Review Board. Informed consent was obtained from all participants at the individual US Alzheimer’s Disease Centers. The National Alzheimer’s Coordinating Center data were de-identified. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: VC, SG, and AR are employees and shareholders of F. Hoffmann-La Roche Ltd. SG is a shareholder of Novartis AG. SZ is employed by Genesis Research, the recipient of consulting fees from F. Hoffmann-La Roche Ltd. MV has received research funding from F. Hoffmann-La Roche Ltd and Biogen in past and consults for F. Hoffmann-La Roche Ltd; she receives research funding from NIH and has equity ownership in Abbott Laboratories, Johnson & Johnson, Medtronic, Merck, and Amgen. AG is a partner of Quantify Research, providing consultancy services to pharmaceutical companies, as well as other private and public organizations and institutions.